Background: Aggressive periodontitis (AgP) is influenced by genetic factors.
account for the significant alveolar bone loss, suggesting that host factors are involved in determining susceptibility to the disease. 4 Although differences in the periodontal microbiota or in other environmental factors may have an influence on AgP occurrence, the individual genetic background is a crucial factor that influences systemic or host response-related risk. [4] [5] [6] Genetic factors regulate the immune system, and specific genetic variations may render an immune system defective and unable to successfully fend off assaults by periodontopathogens. 6, 7 AgP etiology can be explained to a greater extent by genetic factors when compared to CP, which have a major contribution from environmental and lifestyle factors. 6, 8 However, although some studies have been performed to identify single nucleotide polymorphisms (SNPs) associated with AgP, few genetic risk factors that contribute to its pathogenesis have been consistently determined. 8, 9 Several studies have reported such efforts but shown varying, if not contradictory results. [8] [9] [10] Up to date, few genes have been properly identified as susceptibility ones. Some studies had reported a significant or a suggestive association between SNPs in GLT6D1, ANRIL, and IL10 and AgP. 8, [11] [12] [13] [14] [15] The studies that showed statistical evidence or suggestion of associations between AgP and SNPs in GLT6D1 (rs1537415), IL10 (rs6667202), and ANRIL (rs1333048) genes were carried out and replicated in different European populations. [11] [12] [13] [14] 16 The association between rs1537415 (GLT6D1) and AgP was also observed in a Sudanese population. 15 However, these associations were not significant in some populations that were also geographically close. Although IL10 SNP rs6667202 was identified in a German population and confirmed in a smaller German-Austrian cohort, this association was not significant in AgP from a Dutch cohort. 14 Similarly, rs1333048 in ANRIL was first associated with AgP in a German cohort in the study of Schaefer et al., 11 and also observed in the study of Ernst et al., 16 which evaluated German and Northern Irish AgP patients. These associations were also suggested in a small Turkish cohort, but not significant in a small Italian cohort of AgP patients. 14 Although these different results may be because of methodological issues, different genetic profiles found between individual from different populations may also be a relevant factor in these contradictory results. 15, 17 Because genotype and allele frequencies can vary between different ethnic populations, a genetic risk factor for disease susceptibility in one population may not be a risk factor in another population. 4, 7, 15 In this context, findings on significant SNPs being related to a disease should be extensively replicated and validated in independent cohorts.
Therefore, this study focused on investigating whether previously reported associations of rs1537415 (GLT6D1), rs6667202 (IL10), and rs1333048 (ANRIL) with AgP in European populations could be replicated in a population from Brazil. This sounds important because the Brazilian population has a higher prevalence of AgP than the European population (5.5% versus 0.2%) 18, 19 and a great ethnicity miscegenation, which can significantly influence individual genetic backgrounds and determine different genetic risk factors. In addition, the results of AgP were also compared with CP, investigating if these associations were solely attributed to AgP or common genetic background of periodontal destruction.
MATERIALS AND METHODS

Study population
The study was approved by the Ethics Committee of the University of Campinas (58679416.4.0000.5418), and it was designed in accordance with the STROBE Statement for observational studies. The following clinical parameters were assessed in all patients: full-mouth plaque index (FMPI), 20 full-mouth bleeding score (FMBS), 21 probing pocket depth (PPD), and clinical attachment level (CAL) at six point around each tooth using a manual periodontal probe (PCPUNC 15 ® , Hu-Friedy, Chicago, IL). All examinations were performed by experienced periodontists (RCVC, MGC and MPS), one in each center. Tooth mobility, radiographic examination, and complete medical and dental questionnaires were also obtained.
AgP and CP patients were identified on the basis of 1999 International Workshop for the Classification of Periodontal Diseases and Conditions. 1 Most of AgP patients were treated in previous studies [22] [23] [24] [25] or in one of the three Graduate Clinics. Further, these patients needed at the first examination the presence of at least 20 teeth, at least 8 teeth with a PD ≥ 5 mm with bleeding on probing (having at least 2 with PPD ≥ 7 mm), < 35 years of age for AgP patients, and > 35 years for CP. Healthy patients did not show interproximal attachment loss and probing pocket depths of > 4 mm. 26, 27 Additional exclusion criteria were as follows: smoking or previous history of smoking, as established via a questionnaire, diabetes, hepatitis, HIV infection, other systemic diseases (e.g. cardiovascular disease, systemic lupus erythematosus, etc.), use of immunosuppressive drugs, prolonged use of anti-inflammatory drugs, use of orthodontic appliances, and diseases of the oral hard and soft tissues (except caries and periodontitis). 28
Isolation of genomic DNA
Genomic DNA (gDNA) was isolated from buccal epithelial cells using a salting-out protocol. 29 Briefly, the patients undertook a mouthwash containing 5 mL 3% dextrose solution for 60 seconds. Three mL of TNE solution [17 mM Tris/HCl (pH 8.0), 50 mM NaCl, and 7 mM EDTA] in 66% ethanol was added to the sample tube collection. Samples were centrifuged (3000 rpm for 10 min), the supernatant was discarded, and the pellet resuspended in 500 L of extraction buffer [10 mM Tris-HCl (pH 8.0), 5 mM EDTA, 0.5% SDS] and 10 L of proteinase K (Sigma Chemical Co., St. Louis, MO) (20 mg/ml) was added. DNA was dissolved in nuclease-free water, and its quantity was evaluated spectrophotometrically using a spectrophotometer (Nanodrop 2000 device, Thermo Scientific, Wilmington, DE).
Genotyping
PCR-based genotyping of rs1537415 (GLT6D1), rs6667202 (IL10), and rs1333048 (ANRIL) ( Table 1) was performed on the thermocycler (LightCycler 480, Roche Diagnostics, GmbH, GR) using predesigned 5 ′ -nuclease allelic discrimination assays (Thermo Scientific). PCR were carried out in a total of 10 l, containing 20 ng of gDNA, 5 l of a genotyping master mix (Thermo Scientific), 0.5 l probes assay mix 20 × (Thermo Scientific). PCRs were performed under the following conditions: 10 minutes at 95 • C, 40 × (15 seconds at 95 • C, 1 minute at 60 • C). Reactions were randomly repeated in 10% of the samples for each SNP, for quality control purposes, and the concordance rate was 100%. 30 All samples were successfully genotyped, with a genotype call rate of 100%. To test deviations of Hardy-Weinberg equilibrium, genotype distribution of each polymorphism in each group was evaluated by a statistical software (BioEstat 5.4, Belém, PA, BR). Association analysis between rs1537415 (GLT6D1), rs6667202 (IL10), rs1333048 (ANRIL), and AgP was performed using chi-square test ( 2 ). The odds ratio associated with the 95% confidence interval was also calculated. A Stepwise logistic regression was used to determine the best model to AgP diagnosis (dependent variable), considering gender, ethnic group (Caucasoid and African American), and all SNPs (allele and genotype associated to disease) as independent variables using a specific statistical software (SIGMAstat 4.0, Systat, CA). A Bonferroni-adjusted p-value of ≤ 0.017 (0.05/3) was considered statistically significant for the genotyping analysis. Power calculations were performed using a specific software (Quanto 1.2.4 software, University of Southern California, CA), assuming a prevalence of AgP in Brazil of 0.0549, 18 a p value < 0.05 and using the most conservative odds ratios reported in the original studies.
Statistical analysis
RESULTS
Study population
The demographic and clinical characteristics of the patients enrolled in this study at the moment of patient recruitment and sampling of the buccal epithelial cells are shown in Table 2 . The mean age of the AgP patients was 34.0 ± 4.6 years, which was statistically younger than that of the CP (50.0 ± 7.2 years, p < 0.05). However, there was no difference in age between the AgP and healthy groups (30.7 ± 5.8), but the healthy patients were significantly younger than the CP (p < 0.05). A larger proportion of females was observed in AgP group compared with CP and H groups. No significant differences were observed between the groups regarding ethnicity and periodontal parameters at the moment of patient recruitment and sampling of buccal epithelial cells.
Genotyping
Hardy-Weinberg equilibrium and power analysis
The genotype frequencies observed for the three SNPs in the three groups were not statistically significantly different 
AgP versus non-AgP
First, the analysis was performed with the chronic periodontitis and healthy patients pooled together in the non-AgP group. SNP rs6667202 (IL10) showed an association with AgP in this Brazilian cohort when compared to non-AgP group. In this group, the genotype frequencies were 57.5% AA, 37.8% AC, and 4.7% CC, resulting in a frequency of 23.5% of the allele C and a carrier frequency of at least one C allele of 42.5%. In the non-AgP group, the frequencies of AA, AC, and CC were 46.2%, 43%, and 10.8%, respectively, resulting in a C allele frequency of 32.3% and carrier frequency of least one C allele of 53.8%. The C minor allele associated with SNP rs6667202 (IL10) was protective of AgP occurrence, presenting odds ratio of 0.64 (95% CI, 0.48-0.86, p = 0.0034) in relation to non-AgP group. The genotype CC presented an odds ratio of 0.34 (95% CI, 0.15-0.73, p = 0.0081) when comparing AgP and the non-AgP group (Table 3) . Allele and genotype frequencies regarding rs1537415 in GLT6D1 and rs1333048 in ANRIL were not significant for AgP diagnosis in this Brazilian cohort after Bonferroni correction.
AgP versus CP or healthy
AgP group was subsequently compared to healthy and CP group separately. In the healthy group, the frequencies of AA, AC, and CC were 42.1%, 47.4%, and 10.5%, respectively, resulting in a C allele frequency of 34.2%, and carrier frequency of least one C allele of 57.9% (Table 4) . The CP group showed genotype frequencies of 50.3% AA, 38.7% AC and 11.0% CC, resulting in a frequency of 30.4% of the allele C and carrier frequency of at least one C allele of 49.7% (Table 4 ). The C minor allele of SNP rs6667202 (IL10) remained protective of AgP occurrence, presenting odds ratios of 0.59 (95% CI, 0.42-0.82, p = 0.0023) and 0.71 (95% CI, 0.50-0.98, p = 0.05) in relation to the healthy and chronic periodontitis groups, respectively. However, the association in relation to CP group was no longer significant after application of a Bonferroni correction for multiple testing. Allele and genotype frequencies regarding rs1537415 in GLT6D1 and SNP rs1333048 in ANRIL were not significant for AgP diagnosis in this Brazilian cohort after Bonferroni correction.
Stepwise logistic regression
Stepwise logistic regression was used to construct a model to indicate AgP diagnosis. Considering the genotype distribution, AgP diagnosis was associated with gender (p < 0.005), and SNP rs6667202 (IL10) (p < 0.001). Regarding allele distribution, AgP diagnosis was associated with age (p < 0.001), gender (p < 0.003), and SNP rs6667202 (IL10) (p < 0.001) ( Table 5 ).
DISCUSSION
The main finding of the present study was the association of rs6667202 in IL10, but not rs1537415 in GLT6D1 and rs1333048 in ANRIL, with AgP in the Brazilian population. The C minor allele and the CC genotype of rs6667202 were protective to AgP when compared to H, CP and when both populations were pooled (non-AgP group). The AC genotype was statistically significant only when compared with AgP and H. To the best of our knowledge, this is the first association found between AgP and the SNP rs6667202 in IL10 in a Brazilian population.
The SNP rs6667202 is present in the upstream region of IL10 and it was first evaluated in the study of Schaefer et al., 14 who showed an association of this SNP and AgP in the evaluated German cohort, but not in the Dutch cohort. Corroborating Schaefer et al.'s trial, 14 in the present study, the minor C allele was less frequently detected in AgP patients compared to H patients. Moreover, the present study demonstrated that the C allele was also less frequently detected in AgP when compared to CP. This is an important and first described result, because CP and AgP are phenotypically different diseases and, based on our findings, could present different genetic backgrounds. Moreover, this finding could represent a way to differentiate the risk for these diseases, which, clinically, could help the future development of individualized treatments and preventive protocols.
Interestingly, the final logistic model included IL10 SNP rs6667202 (allele or genotype) and gender as diagnostic factors to AgP. This result indicates that women who do not present the C allele of rs6667202 in the IL10 gene could represent the high-risk population for AgP. However, some caution should be taken when considering this result. In our population, there was a higher prevalence of females in the AgP cohort. Although several studies have neglected the association with gender, 6, 31 this result should be considered in future studies.
IL10 encodes the cytokine interleukin-10 (IL-10), an anti-inflammatory cytokine that can regulate the expression of proinflammatory cytokines. This cytokine is usually expressed in inflamed periodontal tissues and is associated with lower disease severity, once it promotes the suppression of proinflammatory cytokines. 32, 33 It can be speculated that the minor C allele of rs6667202, which is enriched in the healthy patients, results in increased production of IL-10, because previous studies have shown lower IL-10 levels in the gingival crevicular fluid of AgP patients. 34, 35 Future studies will be important to highlight the impact of this SNP on IL-10 production and on AgP pathogenesis.
Moreover, the results of the present study did not confirm the associations between rs1537415 in GLT6D1 and rs1333048 in ANRIL with AgP in the Brazilian population. SNP rs1333048 is in a regulatory region and not a proteincoding region of ANRIL, and it was identified as being associated with generalized and localized AgP in a large German cohort, 11 and replicated in a German-Northern Irish population. 16 The GLT6D1 SNP rs1537415 was discovered and replicated in 2 independent German cohorts, and also replicated in a Sudanese population. 12, 15 Interestingly, Schaefer et al. 12 reported a statistical significant enrichment of the minor allele of 9.4% to 12%, similar to that reported by Hashim et al. 15 -about 9%. In the present study, no differences between the minor allele frequency between the groups evaluated were noted. These differences emphasize the role of ethnicity in individual genetic background, which in turn reinforces the importance of replication studies in different populations to understand the genetic basis of AgP.
The lack of associations between AgP and rs1537415 (GLT6D1) and rs1333048 (ANRIL) in the present study could be because of some factors. AgP is considered a complex and multifactorial disease; therefore, genetic risk factors can have different effects in different populations. 15, 36, 37 For example, three SNPs in the IL10 gene (rs1800896, rs1800871, and rs1800872) previously associated to CP were not associated with AgP in a Northeastern Brazilian population. 38 On the other hand, in the present study, the SNP rs6667202 of IL10 gene was associated for a Southeastern Brazilian population with AgP. This phenomenon could indicate that other polymorphisms, in another region of the loci, may be associated with the disease in different populations. 8 Further, the present study has some limitations. The main limitation are the modest sample size when compared to expected to periodontal genetic studies. 39 Therefore, modest association of these SNPs and AgP may have been missed. However, power calculations indicated that the sample size provided more than 80% statistical power to detect an association with rs1537415 (GLT6D1), rs1333048 (ANRIL), and rs6667202 (IL10). Moreover, in the present study AgP group consisted of patients suffering or with history of severe form of generalized AgP, as described in the inclusion criteria (early age of onset and higher level of severity at diagnosis). The inclusion of severe disease phenotype are very likely to improve the chance of detecting a disease-associated variant. 39 Also, efforts were made to minimize of environmental and life-style factor, which can act as sources of phenotypic heterogeneity. 39 
CONCLUSION
In conclusion, the SNP rs6667202 in IL10, but not the SNPs rs1537415 in GLT6D1 and rs1333048 in ANRIL, was associated with AgP in the Brazilian population. The minor C allele of rs6667202 was less frequently detected in AgP patients than in healthy patients, suggesting that this SNP may have a protective effect in this Brazilian cohort.
